GSK Russia makes appointment
This article was originally published in Scrip
Michael Crow, general manager of GlaxoSmithKlinePharmaceuticals Russia, has been promoted to vice-president of the GSK division responsible for emerging markets and area manager for ex-Soviet republics (except the Baltic states). A general manager of GSK Pharmaceuticals Russia, who will report to Mr Crow, is to be appointed. Mr Crow joined GSK in 1989 as sales manager for Cyprus, Jordan and Lebanon. He moved to Russia in 2003 after working for three years as director general of the company's subsidiary in Denmark.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.